TELOSAF TRIO 12.5 TABLET

Product Description

Certainly! Heres an SEO-optimized, engaging, and concise product description for TELOSAF TRIO 12.5 TABLET tailored for Trade India and similar B2B platforms: TELOSAF TRIO 12.5 TABLET | Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg) Advanced Hypertension ControlTELOSAF TRIO 12.5 TABLET is a powerful triple-combination antihypertensive formulation combining Telmisartan, Cilnidipine, and Chlorthalidone. This tablet effectively manages high blood pressure through complementary mechanismsblocking angiotensin receptors, relaxing blood vessels, and promoting diuresisoffering comprehensive cardiovascular protection.Key Benefits: Provides robust blood pressure control in resistant hypertension cases Combines ARB, calcium channel blocker, and thiazide diuretic for enhanced efficacy Reduces risk of stroke, heart attack, and kidney complications Improves patient adherence with once-daily dosing Ideal For: Medical distributors, pharmaceutical retailers, and bulk buyers targeting hospitals, clinics, and healthcare providers focused on advanced hypertensive therapies.Usage: Recommended for patients with essential hypertension requiring multi-drug therapy to achieve optimal blood pressure targets.Why TELOSAF TRIO 12.5? Manufactured under stringent quality controls, TELOSAF TRIO ensures consistent potency and safety, making it a trusted choice for pharma partners and healthcare professionals.